Blass, John P

Publications

Sort by

Co-Author Network

selected publications

Abnormalities in the tricarboxylic acid (TCA) cycle in the brains of schizophrenia patients. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. 2010 Academic Article GET IT
Times cited: 66
Cause and consequence: mitochondrial dysfunction initiates and propagates neuronal dysfunction, neuronal death and behavioral abnormalities in age-associated neurodegenerative diseases. Biochimica et biophysica acta. 2009 Review GET IT
Times cited: 200
A new approach to treating Alzheimer's disease. Annals of the New York Academy of Sciences. 2008 Review GET IT
Times cited: 11
Intensive nutritional supplements can improve outcomes in stroke rehabilitation. Neurology. 2008 Academic Article GET IT
Times cited: 85
Admission C-reactive protein does not predict functional outcomes in patients with strokes in a subacute rehabilitation unit. American journal of physical medicine & rehabilitation. 2008 Academic Article GET IT
Times cited: 2
Increased levels of gamma-glutamylamines in Huntington disease CSF. Journal of neurochemistry. 2008 Academic Article GET IT
Times cited: 49
Randomized clinical stroke trials in 2006. Current vascular pharmacology. 2008 Review GET IT
Times cited: 1
Thiamine-dependent processes and treatment strategies in neurodegeneration. Antioxidants & redox signaling. 2007 Review GET IT
Times cited: 79
Testing for linkage and association across the dihydrolipoyl dehydrogenase gene region with Alzheimer's disease in three sample populations. Neurochemical research. 2007 Academic Article GET IT
Times cited: 11
Mitochondrial aconitase is a transglutaminase 2 substrate: transglutamination is a probable mechanism contributing to high-molecular-weight aggregates of aconitase and loss of aconitase activity in Huntington disease brain. Neurochemical research. 2005 Academic Article GET IT
Times cited: 44
Randomized clinical stroke trials in 2004. Current atherosclerosis reports. 2005 Review GET IT
Times cited: 1
What is aging? What is its role in Alzheimer's disease? What can we do about it?. Journal of Alzheimer's disease : JAD. 2005 Academic Article GET IT
Times cited: 21
Transglutaminase activity is present in highly purified nonsynaptosomal mouse brain and liver mitochondria. Biochemistry. 2005 Academic Article GET IT
Times cited: 48
Mitochondrial abnormalities in Alzheimer brain: mechanistic implications. Annals of neurology. 2005 Academic Article GET IT
Times cited: 446
Association of the dihydrolipoamide dehydrogenase gene with Alzheimer's disease in an Ashkenazi Jewish population. American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics. 2004 Academic Article GET IT
Times cited: 16
Clinically approved heterocyclics act on a mitochondrial target and reduce stroke-induced pathology. The Journal of experimental medicine. 2004 Academic Article GET IT
Times cited: 86
Randomized clinical stroke trials in 2003. Current atherosclerosis reports. 2004 Review GET IT
Times cited: 1
Substantial linkage disequilibrium across the dihydrolipoyl succinyltransferase gene region without Alzheimer's disease association. Neurochemical research. 2004 Academic Article GET IT
Times cited: 7
Mitochondrial enzymes in schizophrenia. Journal of molecular neuroscience : MN. 2004 Academic Article GET IT
Times cited: 39
Cross linking of polyglutamine domains catalyzed by tissue transglutaminase is greatly favored with pathological-length repeats: does transglutaminase activity play a role in (CAG)(n)/Q(n)-expansion diseases?. Neurochemistry international. 2002 Review GET IT
Times cited: 66
The role of transglutaminases in neurodegenerative diseases: overview. Neurochemistry international. 2002 Editorial Article GET IT
Times cited: 22
N(epsilon)-(gamma-L-glutamyl)-L-lysine (GGEL) is increased in cerebrospinal fluid of patients with Huntington's disease. Journal of neurochemistry. 2001 Academic Article GET IT
Times cited: 82
A sensitive fluorometric assay for tissue transglutaminase. Analytical biochemistry. 2001 Academic Article GET IT
Times cited: 28
The alpha-ketoglutarate dehydrogenase complex in neurodegeneration. Neurochemistry international. 2000 Review GET IT
Times cited: 171
Modulation by DLST of the genetic risk of Alzheimer's disease in a very elderly population. Annals of neurology. 1999 Academic Article GET IT
Times cited: 37
Absence of neuronal and glial proteins in human and rat leptomeninges in situ. Journal of the neurological sciences. 1996 Academic Article GET IT
Times cited: 1
Chromosomal fragility associated with familial Alzheimer's disease. Annals of neurology. 1994 Academic Article GET IT
Times cited: 4
Localization of the gene (OGDH) coding for the E1k component of the alpha-ketoglutarate dehydrogenase complex to chromosome 7p13-p11.2. Genomics. 1994 Academic Article GET IT
Times cited: 20
Light microscopic immunocytochemical localization of pyruvate dehydrogenase complex in rat brain: topographical distribution and relation to cholinergic and catecholaminergic nuclei. The Journal of neuroscience : the official journal of the Society for Neuroscience. 1987 Academic Article GET IT
Times cited: 39
Regional distribution of astrocytes with intense immunoreactivity for glutamate dehydrogenase in rat brain: implications for neuron-glia interactions in glutamate transmission. The Journal of neuroscience : the official journal of the Society for Neuroscience. 1987 Academic Article GET IT
Times cited: 137
Glial glutamate dehydrogenase: ultrastructural localization and regional distribution in relation to the mitochondrial enzyme, cytochrome oxidase. Journal of neuroscience research. 1987 Academic Article GET IT
Times cited: 79
Dexamethasone suppression test in depression with reversible dementia. Psychiatry research. 1985 Academic Article GET IT
Times cited: 21
An immunochemical study of the pyruvate dehydrogenase deficit in Alzheimer's disease brain. Annals of neurology. 1985 Academic Article GET IT
Times cited: 148
Toward an effective treatment of Alzheimer's disease. Annals of internal medicine. 1983 Editorial Article GET IT
Times cited: 10

more ...

less ...

Background

education and training

M.D., Columbia University College of Physicians and Surgeons 1965
Ph.D., University of London (United Kingdom) 1960
A.B., Harvard University 1958

Contact

full name

John P Blass

VIVO Weill Cornell Medical College

John P Blass Professor Emeritus of Neurology

Publications

selected publications

Background

education and training

Contact

full name

Phone

Publications

selected publications

Background

education and training

Contact

full name